BRYAN BURT to Adenocarcinoma
This is a "connection" page, showing publications BRYAN BURT has written about Adenocarcinoma.
Connection Strength
2.011
-
Therapeutic Targeting of Macrophage Plasticity Remodels the Tumor-Immune Microenvironment. Cancer Res. 2022 07 18; 82(14):2593-2609.
Score: 0.491
-
Programmed death ligand 1-associated antitumor immunity in early-stage non-small cell lung cancer: Expression of major histocompatibility complex I as a prerequisite. J Thorac Cardiovasc Surg. 2018 01; 155(1):393-394.
Score: 0.350
-
Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer. Ann Surg. 2017 08; 266(2):297-304.
Score: 0.348
-
Progression of EGFR-Mutant Lung Adenocarcinoma is Driven By Alveolar Macrophages. Clin Cancer Res. 2017 Feb 01; 23(3):778-788.
Score: 0.325
-
Clinical Understaging, Treatment Response, and Survival Among Esophageal Adenocarcinoma Patients. J Surg Res. 2022 11; 279:256-264.
Score: 0.123
-
Staging Concordance and Guideline-Concordant Treatment for Esophageal Adenocarcinoma. Ann Thorac Surg. 2022 Jan; 113(1):279-285.
Score: 0.111
-
Prognostic value of neoadjuvant treatment response in locally advanced esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2019 04; 157(4):1682-1693.e1.
Score: 0.096
-
IL17A Regulates Tumor Latency and Metastasis in Lung Adeno and Squamous SQ.2b and AD.1 Cancer. Cancer Immunol Res. 2018 06; 6(6):645-657.
Score: 0.091
-
A dominant adenocarcinoma with multifocal ground glass lesions does not behave as advanced disease. Ann Thorac Surg. 2013 Aug; 96(2):411-8.
Score: 0.066
-
Diameter of non-small cell lung cancer correlates with long-term survival: implications for T stage. Chest. 2005 Nov; 128(5):3255-60.
Score: 0.010